Qing-Shan Li, Yao Li, Girdhar Singh Deora and Ban-Feng Ruan* Pages 809 - 825 ( 17 )
Resveratrol is a non-flavonoid polyphenol containing a terpenoid backbone. It has been intensively studied because of its various promising biological properties, such as anticancer, antioxidant, antibacterial, neuroprotective and anti-inflammatory activities. However, the medicinal application of resveratrol is constrained by its poor bioavailability and stability. In the past decade, more attention has been focused on making resveratrol derivatives to improve its pharmacological activities and pharmacokinetics. This review covers the literature published over the past 15 years on synthetic analogues of resveratrol. The emphasis is on the chemistry of new compounds and relevant biological activities along with structure-activity relationship. This review aims to provide a scientific and reliable basis for the development of resveratrol-based clinical drugs.
Resveratrol, antioxidants, anticancer, anti-inflammatory, structure-activity relationship, roots of white hellebore.
School of Biological and Medical Engineering, Hefei University of Technology, Hefei, 230009, School of Biological and Medical Engineering, Hefei University of Technology, Hefei, 230009, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, School of Biological and Medical Engineering, Hefei University of Technology, Hefei, 230009